CenterWatch

Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Oncology | Nephrology | Family Medicine
Disease Category: Kidney Cancer
Location: United States, WV

Clinical Trial Details

Overview

Research Study Summary

ECOG1808-A Randomized Phase II Trial of Sunitinib/Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features

Purpose

Objective- To evaluate response rate of both the combination of sunitinib and gemcitabine and sunitinib alone in patients with advanced renal cell carcinoma with sarcomatoid features. To evaluate progression-free survival following treatment with both the combination of sunitinib and gemcitabine and sunitinib alone in this patient population.

To Learn more

CW ID:170778
Date Last Changed: July 22, 2013

Clinical Trial Snapshot

Phase
2
Gender
Both Male and Female
Age
N/A
Overall Status
Recruiting
Facility Type
N/A

Contact

West Virginia University - Clinical Trials Research Unit
1637 Health Sciences South
Morgantown, WV 26506
Phone: 304-293-4944

View Map

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.